Updates on Interstitial Lung Disease
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pulmonology".
Deadline for manuscript submissions: 28 February 2025 | Viewed by 183
Special Issue Editors
Interests: lung disease; lung transplantation; asthma; bronchitis; bronchoscopy; bronchogenic carcinoma; carcinoid syndrome; congenital lung disease; histoplasmosis; Lambert–Eaton myasthenic syndrome; lung cancer; malignant mesothelioma
Special Issue Information
Dear Colleagues,
Interstitial lung disease is an important cause of end-stage lung disease and is the most common indication for lung transplantation. Accurate, early diagnosis and the initiation of appropiate treatment remain essential. Recent advances in the diagnosis and treatment of ILD are promising. For the diagnosis of ILD, lung biopsy techniques, radiology, and biomarkers have aided in a less invasive and earlier diagnosis. Treatment for ILD remains focused on slowing the progression of fibrotic disease and immune modulation for inflammatory ILD. Studies targeting several pathways and ongoing clinical trials have yielded promising early results. Updated guidelines for the treatment of fibrotic ILD and CTD-ILD have been recently published. Thus, in this Special Issue, we would like to focus on recent updates in the diagnosis and management of ILD, with invited review articles from leaders in the field.
Prof. Dr. Atul C. Mehta
Dr. Sameep Sehgal
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- interstitial lung disease
- idiopathic pulmonary fibrosis
- lung transplantation
- connective tissue disease
- bronchoscopy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
